Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study

BACKGROUND. Direct-acting antivirals (DAA) allow effective and safe eradication of hepatitis C virus (HCV) in most patients. There are limited data on the long-term effects of all-oral, interferon-free DAA combination therapies in kidney transplant (KT) patients infected with HCV. Here we evaluated...

Full description

Saved in:
Bibliographic Details
Published in:Transplant Direct
Main Authors: González-Corvillo, Carmen, Beneyto, Isabel, Sánchez-Fructuoso, Ana, Perelló, Manel, Alonso, Angel, Mazuecos, Auxiliadora, Jiménez, Carlos, Zárraga, Sofía, Paul, Javier, Lauzurica, Ricardo, Hernández, Domingo, Guirado, Luis, Franco, Antonio, Ruiz, Juan Carlos, Llorente, Santiago, Crespo, Marta, Rodríguez-Benot, Alberto, de Gracia Guindo, María del Carmen, Díaz-Corte, Carmen, Gentil, Miguel Ángel
Format: Artigo
Language:Inglês
Published: Wolters Kluwer Health 2019
Subjects:
Kidney Transplantation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004590/
https://ncbi.nlm.nih.gov/pubmed/32095505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000954
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items